Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Gr. Regulatory News (JGC)

Share Price Information for Jupiter Gr. (JGC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 177.00
Ask: 178.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.565%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
JGC Live PriceLast checked at -
Jupiter Green is an Investment Trust

To achieve capital growth and income, both over the long term, through investment in a diverse portfolio of companies providing environmental solutions.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter Green Investment Trst (JGC)

14 Mar 2019 15:26

RNS Number : 9319S
Jupiter Green Investment Trust Plc
14 March 2019
 

 

London, UK, 14 March 2019

Edison issues review on Jupiter Green Investment Trust (JGC)

Jupiter Green Investment Trust (JGC) is continuing to benefit from the greater public interest in green issues, which is driving demand growth for companies delivering solutions to environmental challenges. Manager Charlie Thomas and his team run a globally diversified portfolio of c 60 companies, invested across a wide variety of areas, broadly grouped into themes of resource efficiency, demographics and infrastructure. The growing maturity of the investment universe is leading to a larger number of companies paying attractive dividends, enabling JGC to enhance its own dividend policy, with a higher yield (now c 1.3%, from c 0.7%) and semi-annual payouts. As the highest-yielding, closed-ended 'green' equity fund, JGC could see greater demand for its shares, which could help to narrow the currently wider-than-average discount to NAV.

 

JGC's current 5.8% share price discount to cum-income NAV (at 13 March 2019) is wider than the average discounts over one, three and five years, which range from 4.4% to 5.5%. The discount widened from a 0.9% premium in October 2018 as JGC's share price fell amid market volatility, and has remained wider than the medium-term average as the NAV has outperformed the recovering share price. The introduction of a higher, semi-annual dividend may help boost demand for JGC's shares.

Click here to view the full report.

 

SUBSCRIBE TO EDISON'S CONTENT and receive reports emailed directly to you.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Sarah Godfrey, +44 (0)20 3681 2519

Mel Jenner, +44 (0)20 3077 5720

investmenttrusts@edisongroup.com

 

Learn more at Edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAJIMATMBTBBJL
Date   Source Headline
8th Jan 20242:46 pmRNSPortfolio Update
8th Jan 202411:40 amRNSNet Asset Value(s)
5th Jan 20245:10 pmRNSTransaction in Own Shares
5th Jan 202412:45 pmRNSNet Asset Value(s)
4th Jan 202412:46 pmRNSNet Asset Value(s)
3rd Jan 202412:03 pmRNSNet Asset Value(s)
2nd Jan 202412:21 pmRNSTotal Voting Rights
2nd Jan 202412:15 pmRNSNet Asset Value(s)
29th Dec 202311:23 amRNSNet Asset Value(s)
28th Dec 202311:43 amRNSNet Asset Value(s)
27th Dec 202312:22 pmRNSNet Asset Value(s)
22nd Dec 20231:03 pmRNSTransaction in Own Shares
22nd Dec 202312:15 pmRNSNet Asset Value(s)
21st Dec 202312:35 pmRNSNet Asset Value(s)
20th Dec 202312:24 pmRNSNet Asset Value(s)
20th Dec 202310:25 amRNSResults analysis from Kepler Trust Intelligence
19th Dec 202311:56 amRNSNet Asset Value(s)
18th Dec 20232:50 pmRNSHalf-year Report
18th Dec 202312:25 pmRNSNet Asset Value(s)
15th Dec 202312:40 pmRNSNet Asset Value(s)
14th Dec 202312:04 pmRNSNet Asset Value(s)
13th Dec 202312:53 pmRNSNet Asset Value(s)
12th Dec 202311:32 amRNSNet Asset Value(s)
11th Dec 202311:22 amRNSNet Asset Value(s)
8th Dec 20235:20 pmRNSTransaction in Own Shares
8th Dec 202311:50 amRNSNet Asset Value(s)
7th Dec 202311:27 amRNSNet Asset Value(s)
6th Dec 202311:19 amRNSNet Asset Value(s)
5th Dec 202311:28 amRNSNet Asset Value(s)
4th Dec 202312:49 pmRNSNet Asset Value(s)
1st Dec 20235:11 pmRNSTransaction in Own Shares
1st Dec 202311:50 amRNSNet Asset Value(s)
1st Dec 202311:41 amRNSTotal Voting Rights
30th Nov 202311:27 amRNSNet Asset Value(s)
29th Nov 202311:27 amRNSNet Asset Value(s)
28th Nov 202311:24 amRNSNet Asset Value(s)
27th Nov 202311:43 amRNSNet Asset Value(s)
24th Nov 202311:44 amRNSNet Asset Value(s)
23rd Nov 202311:39 amRNSNet Asset Value(s)
22nd Nov 202311:50 amRNSNet Asset Value(s)
21st Nov 202311:40 amRNSNet Asset Value(s)
20th Nov 202311:47 amRNSNet Asset Value(s)
17th Nov 20235:07 pmRNSTransaction in Own Shares
17th Nov 202312:35 pmRNSNet Asset Value(s)
16th Nov 202312:26 pmRNSNet Asset Value(s)
15th Nov 202311:40 amRNSNet Asset Value(s)
14th Nov 202312:07 pmRNSNet Asset Value(s)
13th Nov 202312:20 pmRNSNet Asset Value(s)
10th Nov 20235:14 pmRNSTransaction in Own Shares
10th Nov 202312:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.